(1) Where an employee applies for a leave of absence to receive subfertility treatment (hereinafter referred to as "leave of absence for subfertility treatment") such as artificial insemination or in vitro fertilization, an employer shall grant a leave of absence to the employee for a period not exceeding six days a year, and in such cases, the first two days shall be a paid leave of absence; provided, where granting a leave of absence for a period as requested by the employee significantly impedes the operation of normal business, the employer may change the period in consultation with the employee. <Amended on Oct. 22, 2024>
(2) No employer shall give disadvantageous treatment such as dismissal or disciplinary punishment on the ground of leave of absence for subfertility treatment.
(3) No employer shall disclose to any other person any fact he or she has learned in the course of processing the request for leave of absence for subfertility treatment pursuant to paragraph (1) against the will of the employee who has applied for the leave. <Amended on Oct. 22, 2024>
(4) Methods, procedures, etc. for applying for a leave of absence for subfertility treatment shall be prescribed by Presidential Decree. <Added on Oct. 22, 2024>[This Article Added on Nov. 28, 2017]